DEF 14C: La Rosa Holdings Secures Key Stockholder Approvals for Share Issuance and Equity Plan Expansion
Information Statement
La Rosa Holdings Corp. has received majority stockholder approval for the issuance of new conversion shares exceeding 19.99% of common stock to comply with Nasdaq rules and for an expanded equity incentive plan.
Summary
- Majority stockholders, led by CEO Joseph La Rosa, approved two key corporate actions with 97.2% of outstanding voting capital stock.
- Approved the issuance of New Conversion Shares in excess of 19.99% of the company's issued and outstanding Common Stock to comply with Nasdaq's 20% Rule, related to the conversion of Series B Convertible Preferred Stock issued to an institutional investor.
- Approved the Second Amended and Restated 2022 La Rosa Holdings Corp. Equity Incentive Plan, increasing the total shares available for grants from 156,250 to 374,961 shares and clarifying the definition of 'Consultant'.
- The actions will become effective approximately August 11, 2025, twenty days after the information statement is mailed on or about July 21, 2025.
Sentiment
Score: 6
Explanation: The filing indicates successful completion of necessary corporate governance steps, which is positive for compliance and operational flexibility. However, the potential for significant dilution from the convertible preferred stock, especially at low conversion prices, introduces a negative aspect for existing common shareholders.
Positives
- Secured necessary stockholder approval (97.2% majority) for critical corporate actions, ensuring compliance with Nasdaq listing rules.
- Expansion of the equity incentive plan to 374,961 shares provides more flexibility for attracting and retaining talent.
- The company is proactively addressing Nasdaq listing requirements by seeking stockholder approval for potential dilutive issuances, which helps maintain its listing status.
Negatives
- The issuance of New Conversion Shares could lead to significant dilution for existing common stockholders, as conversions may involve 'many times more than 20%' of outstanding common stock.
- The Series B Preferred Stock has a conversion price that can adjust downwards (Alternate Conversion Price as low as $0.082), potentially leading to further dilution if the stock price declines.
- The Series B Preferred Stock conversion amount is multiplied by 125% (or 105% for Change of Control) when converting at the Alternate Conversion Price, which increases the number of shares issued upon conversion.
Risks
- Potential for significant dilution of common stock due to the conversion of Series B Preferred Stock, especially if the Alternate Conversion Price is utilized, which could negatively impact per-share value.
- The company's ability to redeem Series B Preferred Stock is at a price equal to the greater of the Conversion Amount or a price based on the greatest Closing Sale Price, which could be a costly obligation.
Future Outlook
The company expects the approved corporate actions, including the issuance of new conversion shares and the amended equity incentive plan, to become effective around August 11, 2025, ensuring compliance with Nasdaq listing rules and providing sufficient shares for future equity grants.
Management Comments
- Our Board of Directors is not soliciting your consent or your proxy in connection with these Corporate Actions and neither consents nor proxies are being requested from stockholders.
- The actions taken by written consent of the Majority Stockholders will not become effective until the date that is twenty (20) calendar days after this Information Statement is first mailed or otherwise delivered to holders of our Common Stock as of the Record Date.
Industry Context
This filing reflects a common practice for publicly traded companies to seek stockholder approval for significant equity issuances and adjustments to incentive plans, particularly when dealing with convertible securities that could trigger exchange listing rules like Nasdaq's 20% Rule. It demonstrates the company's adherence to regulatory requirements to maintain its listing status.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Related Party Transactions
- Joseph La Rosa, the Chief Executive Officer, President, and Chairman of the Board, along with JLR-JCCLT1 Land Trust (controlled by Mr. La Rosa), collectively hold approximately 97.2% of the outstanding voting capital stock and provided the written consent for the corporate actions.
- Mr. La Rosa executed a voting agreement with the company to vote in favor of the Stockholder Approval related to the Series B Preferred Stock conversion.
- Mr. La Rosa's beneficial ownership includes shares owned by Celebration Office Condos, LLC (an entity owned and controlled by him) and shares held by his adult children living in his household.
Stakeholder Impact
- Shareholders: Potential for significant dilution of common stock due to the conversion of Series B Preferred Stock, especially if the stock price declines and the Alternate Conversion Price is used. However, the approval ensures Nasdaq listing compliance, which is beneficial for liquidity and market access.
- Employees/Management: The expanded equity incentive plan provides more shares for future grants, which can be used to attract, retain, and motivate employees, officers, directors, and consultants.
- Institutional Investor: The investor received Series B Convertible Preferred Stock in exchange for warrants, with conversion rights that could yield a substantial number of common shares.
Next Steps
- The approved corporate actions will become effective approximately August 11, 2025.
- The company will continue to file reports with the SEC as required by the Exchange Act.
Key Dates
| Date | Description |
|---|---|
| 2022-01-10 | Original adoption date of the La Rosa Holdings Corp. 2022 Equity Incentive Plan by the Board and stockholders. |
| 2023-11-01 | Grant date for a 10-year fully vested stock option to Michael A. La Rosa and Ned L. Siegel. |
| 2023-12-04 | Grant date for a 10-year fully vested stock option to Joseph La Rosa. |
| 2023-12-07 | Grant date for a 10-year fully vested stock option to Joseph La Rosa. |
| 2024-01-02 | Grant date for a 10-year fully vested stock option to Joseph La Rosa. |
| 2024-02-01 | Grant date for a 10-year fully vested stock option to Joseph La Rosa and Deana La Rosa. |
| 2024-03-15 | Grant date for a 10-year fully vested stock option to Joseph La Rosa. |
| 2024-06-18 | Grant date for a 10-year fully vested stock option to Joseph La Rosa. |
| 2024-11-19 | Adoption date of the Amended and Restated La Rosa Holdings 2022 Equity Incentive Plan by stockholders. |
| 2025-01-02 | Grant date for a 10-year fully vested stock option to Joseph La Rosa. |
| 2025-02-04 | Company and an institutional investor entered into a Securities Purchase Agreement for a Senior Secured Convertible Note and Incremental Warrants. |
| 2025-06-18 | Company and Investor entered into and closed transactions contemplated by the Amendment and Exchange Agreement; Company filed Certificate of Designation of Rights and Preferences of Series B Preferred Stock. |
| 2025-06-20 | Date of filing Current Report on Form 8-K with the Commission regarding the Exchange Agreement. |
| 2025-07-07 | Effective date of the 80-for-1 reverse stock split. |
| 2025-07-09 | Record Date for stockholders; Date Majority Stockholders approved Corporate Actions by written consent; Compensation Committee and Board of Directors approved the Second Amended and Restated 2022 La Rosa Holdings 2022 Equity Incentive Plan. |
| 2025-07-14 | Company and Investor entered into Amendment No. 1 to the Exchange Agreement; Company filed a Certificate of Correction to the Certificate of Designation. |
| 2025-07-16 | Date of filing Current Report on Form 8-K with the Commission regarding the Certificate of Correction. |
| 2025-07-21 | Date of the Information Statement mailing to stockholders. |
| 2025-08-11 | Approximate effective date of the Corporate Actions (20 days after mailing of Information Statement). |
| 2032-01-10 | Termination date of the Second Amended and Restated 2022 Equity Incentive Plan. |
Recommendation
holdThe filing indicates successful completion of necessary corporate governance steps, which is positive for compliance and operational flexibility. However, the potential for significant dilution from the convertible preferred stock, especially at low conversion prices, introduces a negative aspect for existing common shareholders. The overall impact is mixed, suggesting a 'hold' position until the full implications of the dilution and the company's future performance become clearer.
Keywords
La Rosa Holdings Corp., SEC Filing, DEF 14C, Stockholder Approval, Nasdaq Compliance, Equity Incentive Plan, Share Dilution, Convertible Preferred Stock, Corporate Governance, Joseph La Rosa, Series B Preferred Stock, Series X Super Voting Preferred Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.